These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
314 related items for PubMed ID: 27699544
1. Cancer Immunology and HPV. Wollenberg B. Recent Results Cancer Res; 2017; 206():243-248. PubMed ID: 27699544 [Abstract] [Full Text] [Related]
2. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. Braakhuis BJ, Snijders PJ, Keune WJ, Meijer CJ, Ruijter-Schippers HJ, Leemans CR, Brakenhoff RH. J Natl Cancer Inst; 2004 Jul 07; 96(13):998-1006. PubMed ID: 15240783 [Abstract] [Full Text] [Related]
4. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients. Descamps G, Karaca Y, Lechien JR, Kindt N, Decaestecker C, Remmelink M, Larsimont D, Andry G, Hassid S, Rodriguez A, Khalife M, Journe F, Saussez S. J Cancer Res Clin Oncol; 2016 Oct 07; 142(10):2185-96. PubMed ID: 27370781 [Abstract] [Full Text] [Related]
5. Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer. Heusinkveld M, Goedemans R, Briet RJ, Gelderblom H, Nortier JW, Gorter A, Smit VT, Langeveld AP, Jansen JC, van der Burg SH. Int J Cancer; 2012 Jul 15; 131(2):E74-85. PubMed ID: 22020783 [Abstract] [Full Text] [Related]
7. Prevalence of human papillomavirus types, viral load and physical status of HPV16 in head and neck squamous cell carcinoma from the South Swedish Health Care Region. Faust H, Eldenhed Alwan E, Roslin A, Wennerberg J, Forslund O. J Gen Virol; 2016 Nov 15; 97(11):2949-2956. PubMed ID: 27667722 [Abstract] [Full Text] [Related]
8. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma. Hajek M, Sewell A, Kaech S, Burtness B, Yarbrough WG, Issaeva N. Cancer; 2017 May 15; 123(10):1778-1790. PubMed ID: 28295222 [Abstract] [Full Text] [Related]
9. Human papillomavirus-positive tonsillar carcinomas: a different tumor entity? Klussmann JP, Weissenborn SJ, Wieland U, Dries V, Eckel HE, Pfister HJ, Fuchs PG. Med Microbiol Immunol; 2003 Aug 15; 192(3):129-32. PubMed ID: 12920586 [Abstract] [Full Text] [Related]
12. Risk Groups for Survival in HPV-Positive and HPV-Negative OPSCC. Rietbergen MM, Brakenhoff RH, René Leemans C. Recent Results Cancer Res; 2017 Aug 15; 206():221-231. PubMed ID: 27699542 [Abstract] [Full Text] [Related]
15. The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. Ragin CC, Modugno F, Gollin SM. J Dent Res; 2007 Feb 15; 86(2):104-14. PubMed ID: 17251508 [Abstract] [Full Text] [Related]
18. Human papillomavirus-related oropharyngeal cancer. Taberna M, Mena M, Pavón MA, Alemany L, Gillison ML, Mesía R. Ann Oncol; 2017 Oct 01; 28(10):2386-2398. PubMed ID: 28633362 [Abstract] [Full Text] [Related]
19. Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population. Maruyama H, Yasui T, Ishikawa-Fujiwara T, Morii E, Yamamoto Y, Yoshii T, Takenaka Y, Nakahara S, Todo T, Hongyo T, Inohara H. Cancer Sci; 2014 Apr 01; 105(4):409-17. PubMed ID: 24521534 [Abstract] [Full Text] [Related]
20. Human papillomavirus status in young patients with head and neck squamous cell carcinoma. van Monsjou HS, van Velthuysen ML, van den Brekel MW, Jordanova ES, Melief CJ, Balm AJ. Int J Cancer; 2012 Apr 15; 130(8):1806-12. PubMed ID: 21607949 [Abstract] [Full Text] [Related] Page: [Next] [New Search]